Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHARP - Sexual Health at Retail Pharmacies
PACTR202607850859928Phase 4Not yet recruiting
- Sponsor
- University of Washington
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of doxycycline in human immunodeficiency virus infection (HIV) and sexually transmitted disease (STD) (3 arms), sponsored by University of Washington. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
doxycycline
03
Conditions
human immunodeficiency virus infection (HIV)sexually transmitted disease (STD)
Beyond the preview
Go deeper on PACTR202607850859928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202607850859928.